why choose us

First received: December 27, 2022

Clinical Trial: Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heterozygous or Homozygous Familial Hypercholesterolemia

Study Type: INTERVENTIONAL


Official Title: An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Hav

Brief Summary: The purpose of this open-label, single arm, multicenter extension study is to evaluate the long-term safety and tolerability of inclisiran in participants with HeFH or HoFH who have completed the ORION-16 or ORION-13 studies.

Read more